PATENT CLAIM ANALYSIS

Application Number: 16038733
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "007200"]

Abstract:
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.

Claim (Index 1):
A method for improving glycemic control in a patient with type 2 diabetes not adequately controlled by treatment with a glitazone, the method comprising administering lixisenatide as an add-on treatment to the patient in need thereof;\n wherein the patient is not adequately controlled by treatment with a glitazone at a dose of 10 mg/day to 60 mg/day; and wherein the lixisenatide is administered at a starting dose of 10 \u03bcg daily and titrated to a maintenance dose of 20 \u03bcg daily by day 15 of lixisenatide treatment.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 95.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14965586', '13467757', '13467707', '14781857', '15237285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7064020783448545
- 35 USC 102 Novelty (BERT): 0.5977199176413274
- Combined Prediction Score: 0.6955338622745018
- Mean Citation Score: 509.022716
- Max Citation Score: 538.7900400000002
- Similarity Product: 461.2296158327724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test